XSAT:GEAN (Norway)
Â
Unit (10 Ordinary shares,6 Wrts Ser 1 & 7 Wrts Ser 2)
kr
0.50
(+1.01%)
Dec 13
Business Description
Genetic Analysis AS
ISIN : NO0010692130
Share Class Description:
XSAT:GEAN: Unit (10 Ordinary shares,6 Wrts Ser 1 & 7 Wrts Ser 2)Compare
Compare
Traded in other countries / regions
GEAN.Sweden8V8.Germany IPO Date
2021-10-01Description
Genetic Analysis AS is a research-driven diagnostic company dedicated to delivering innovative diagnostic solutions to the growing human microbiota market. It is providing a CE-marked gut microbiota analysis for testing bacterial imbalance in IBS and IBD patients.
Financial Strength
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1.29 | |||||
| Equity-to-Asset | 0.56 | |||||
| Debt-to-Equity | 0.38 | |||||
| Debt-to-EBITDA | -0.61 | |||||
| Piotroski F-Score | 4/9 | |||||
| Altman Z-Score | -0.56 | |||||
| Beneish M-Score | -2.79 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 17 | |||||
| 3-Year EBITDA Growth Rate | 9.2 | |||||
| 3-Year EPS without NRI Growth Rate | 9.4 | |||||
| 3-Year FCF Growth Rate | 0.1 | |||||
| 3-Year Book Growth Rate | -23.3 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 36.44 | |||||
| 9-Day RSI | 38.78 | |||||
| 14-Day RSI | 39.13 | |||||
| 3-1 Month Momentum % | -20.27 | |||||
| 6-1 Month Momentum % | -21.33 | |||||
| 12-1 Month Momentum % | -21.33 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 2.26 | |||||
| Quick Ratio | 2.1 | |||||
| Cash Ratio | 1.22 | |||||
| Days Inventory | 125.11 | |||||
| Days Sales Outstanding | 54.93 | |||||
| Days Payable | 396.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -15 | |||||
| Shareholder Yield % | -18.38 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 72.79 | |||||
| Operating Margin % | -187.31 | |||||
| Net Margin % | -151.81 | |||||
| FCF Margin % | -121.71 | |||||
| ROE % | -75.72 | |||||
| ROA % | -45.68 | |||||
| ROIC % | -80.57 | |||||
| 3-Year ROIIC % | -220.55 | |||||
| ROC (Joel Greenblatt) % | -341.53 | |||||
| ROCE % | -59.94 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 1.55 | |||||
| PB Ratio | 1.05 | |||||
| Price-to-Tangible-Book | 3.13 | |||||
| EV-to-EBIT | -1.12 | |||||
| EV-to-Forward-EBIT | -1.56 | |||||
| EV-to-EBITDA | -1.52 | |||||
| EV-to-Revenue | 1.64 | |||||
| EV-to-Forward-Revenue | 0.66 | |||||
| EV-to-FCF | -1.34 | |||||
| Price-to-GF-Value | 0.44 | |||||
| Price-to-Net-Current-Asset-Value | 8.33 | |||||
| Earnings Yield (Greenblatt) % | -89.29 | |||||
| FCF Yield % | -66.6 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Genetic Analysis AS Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil kr) | 13.511 | ||
| EPS (TTM) (kr) | -0.495 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | -1.4 | ||
| 3-Year Sortino Ratio | -1.6 | ||
| Volatility % | 48.29 | ||
| 14-Day RSI | 39.13 | ||
| 14-Day ATR (kr) | 0.03744 | ||
| 20-Day SMA (kr) | 0.51645 | ||
| 12-1 Month Momentum % | -21.33 | ||
| 52-Week Range (kr) | 0.27 - 1.75 | ||
| Shares Outstanding (Mil) | 49.38 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 4 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Genetic Analysis AS Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Genetic Analysis AS Stock Events
| Event | Date | Price (kr) | ||
|---|---|---|---|---|
| No Event Data | ||||
Genetic Analysis AS Frequently Asked Questions
What is Genetic Analysis AS(XSAT:GEAN)'s stock price today?
The current price of XSAT:GEAN is kr0.50. The 52 week high of XSAT:GEAN is kr1.75 and 52 week low is kr0.27.
When is next earnings date of Genetic Analysis AS(XSAT:GEAN)?
The next earnings date of Genetic Analysis AS(XSAT:GEAN) is 2025-02-26.
Does Genetic Analysis AS(XSAT:GEAN) pay dividends? If so, how much?
Genetic Analysis AS(XSAT:GEAN) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers